JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling by Jonas Hjelmgren, Kristoffer Nilsson, Gunnar Birgegård

Get full text

Webbaserad pedagogisk meritportfölj - från idé till verklighet by Jakob Johansson, Karin Apelgren, Gunnar Birgegård, Martin Grydén, Louise Rügheimer

Get full text

Webbaserad pedagogisk meritportfölj - från idé till verklighet by Jakob Johansson, Karin Apelgren, Gunnar Birgegård, Martin Grydén, Louise Rügheimer

Get full text

Webbaserad pedagogisk meritportfölj - från idé till verklighet by Jakob Johansson, Karin Apelgren, Gunnar Birgegård, Martin Grydén, Louise Rügheimer

Get full text

Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid® efficacy and long-term safety study by Luigi Gugliotta, Carlos Besses, Martin Griesshammer, Claire Harrison, Jean-Jacques Kiladjian, Ruth Coll, Jonathan Smith, Brihad Abhyankar, Gunnar Birgegård

Get full text

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safe... by Gunnar Birgegård, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire N. Harrison, Mohamed Hamdani, Jingyang Wu, Heinrich Achenbach, Jean-Jacques Kiladjian

Get full text

The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe by José-Tomás Navarro, Gunnar Birgegård, Janet Strivens, Wietske W.G. Hollegien, Naomi van Hattem, Manon T. Saris, Marielle J. Wondergem, Cheng-Hock Toh, Antonio M. Almeida

Get full text

The Progress Test of the European Hematology Association: A New Tool for Continuous Learning by Marielle J. Wondergem, Antonio Almeida, Janaki Brolin, Carlos Fernandez de Larrea, Nathalie van Havre, Bas T. Hemker, Wietske Hollegien, José-Tomás Navarro, Mahesh Prahladan, Alicia Rovó, Gunnar Birgegård

Get full text

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group by Holly L. Geyer, Heidi Kosiorek, Amylou C. Dueck, Robyn Scherber, Stefanie Slot, Sonja Zweegman, Peter AW te Boekhorst, Zhenya Senyak, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, Heike L. Pahl, Martin Griesshammer, Frank Stegelmann, Konstanze Döhner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Francoise Boyer, Gabriel Etienne, Jean-Christophe Ianotto, Dana Ranta, Lydia Roy, Jean-Yves Cahn, Claire N. Harrison, Deepti Radia, Pablo Muxi, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter L. Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Chiara Paoli, Francesco Passamonti, Bjorn Andreasson, Maria L Ferrari, Alessandro Rambaldi, Jan Samuelsson, Keith Cannon, Gunnar Birgegard, Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Jean-Jacques Kiladjian, Peihong Zhang, Robert Peter Gale, Ruben A. Mesa

Get full text